artificial pancreas
NICE recommends Cambridge-developed ‘artificial pancreas’ for use on NHS for management of type 1 diabetes

The artificial pancreas for type 1 diabetes – which was developed in Cambridge and supported in trials by the NIHR Cambridge BRC and NIHR Cambridge CRF – could soon be approved for use Read more

Gone fishing: highly accurate test for common respiratory viruses uses DNA as ‘bait’

Research supported by NIHR Cambridge BRC has led to a new test that ‘fishes’ for multiple respiratory viruses at once using single strands of DNA as ‘bait’, giving highly accurate results in under Read more

Artificial pancreas app, insulin pump and glucose monitor
Artificial pancreas successfully trialled for use by type 2 diabetes patients

Cambridge researchers have successfully trialled an artificial pancreas for people living with type 2 diabetes. Read more

Professor Krish Chatterjee
Professor Krishna Chatterjee awarded a CBE

Professor Krishna Chatterjee, director of NIHR Cambridge Clinical Research Facility, has been awarded a CBE in the King’s New Year Honours.Read more

Baby with non-invasive sensors on their head to monitor brain activity during sleep. Photo reproduced with permission from Uchitel J et al, Neuroimage 2022 in press.
Cambridge researchers launch study to investigate the impact of neonatal intensive care on premature babies’ sleep patterns and brain development

Cambridge researchers funded by Action Medical Research and the NIHR Cambridge BRC are investigating the impact interruptions in sleep cycles – such as loud noises – have on the development of brain activity Read more

Infected organoid (Credit: Teresa Brevini)
Off-patent liver disease drug could prevent COVID-19 infection

Cambridge scientists have identified an off-patent drug that can be repurposed to prevent COVID-19 – and may be capable of protecting against future variants of the virus – in research part-funded by the Read more

Blood thinning drug to treat recovery from severe Covid is not effective

A Cambridge-led trial has found that a drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe Covid.Read more

Cambridge researchers listed among world’s most influential researchers

Congratulations to our NIHR Cambridge BRC theme leads who have been named in the Clarivate listings of the ‘world’s most influential researchers.’Read more

Prostate cancer blue awareness ribbon
Cambridge researchers develop safe, affordable device for prostate cancer diagnosis

A new medical device developed at Addenbrooke’s and supported by the NIHR Cambridge BRC and NIHR Cambridge Clinical Research Facility aims to reduce the risk of infection in prostate patients – and save Read more

High blood pressure is directly linked to severe COVID-19

A new study has shown people with high blood pressure are more likely to be admitted to hospital or die from COVID-19, regardless of other factors such as age, sex, ethnicity or BMI.Read more

Blood vials being placed in centrifuge
World-first trial to transfuse lab-grown red blood cells is underway in Cambridge

Red blood cells that have been grown in a laboratory have now been transfused into another person at the NIHR Cambridge Clinical Research Facility in a world first clinical trial. Read more

Cambridge BRC receives £86.2 million to translate research discoveries into new treatments for patients

The NIHR has awarded £86.2 million to NIHR Cambridge Biomedical Research Centre investigators to continue their ground-breaking research, translating new scientific insights into state-of-the-art diagnostics and treatments to transform healthcare. Read more

Dementia signs detected as early as nine years ahead of diagnosis

Cambridge scientists have shown that it is possible to spot signs of brain impairment in patients as early as nine years before they receive a diagnosis for one of a number of dementia-related diseases.Read more

Referrals to long COVID clinic fell by 79% following roll-out of the vaccine

Referrals to Cambridge’s long COVID clinic fell dramatically in the period August 2021 to June 2022, which researchers say is likely due to the successful rollout of the vaccine. Read more

Cancer PPI group
Celebrating the role of patients in improving radiotherapy services

A new display in Addenbrooke’s Hospital highlights how patients have helped shape radiotherapy treatment.Read more

Gail Holloway
Welcome to our new Patient and Public Involvement coordinator

Gail will be helping researchers design PPI plans for their studies and run training sessions. Read more

Queen Elizabeth II
NIHR statement on the death of Her Majesty Queen Elizabeth II

We at the NIHR offer our sincerest condolences to the royal family on the passing of Her Majesty Queen Elizabeth II. We share in the grief of the whole nation at the death Read more

Large number of stem cell lines carry significant DNA damage, say researchers

Cambridge researchers say detailed genetic characterisation including whole genome sequencing can help ensure safety of cell-based therapies.Read more

Hundreds more to join Covid study to help protect most at risk

Up to 1,700 more patients from across the UK are being asked to join an Addenbrooke’s led drug trial, to help find ways of protecting those with poor immunity from catching Covid.Read more

Kidney graphic
Research reveals how genetic mutations cause kidney cancer

Researchers at the University of Cambridge have shown that genetic mutations associated with kidney cancer rely on factors that regulate normal kidney cells in order to develop into cancer cells.
The study suggests Read more

Discover more about the NIHR Cambridge BRC

Contact us by phone, email or web for more information.

Events Calendar

Listing relevant events and training sessions for researchers and members of the public.